The following new grants were awarded to JCCC members, announced in November 2012:
Principal Investigator: Arab, Lenore
Sponsor Name: Calif Walnut Commission
Award Title: Analyses of the Associations Between Walnut Consumption and Nutritional Adequacy and Cognitive Function in the U.S. Population
Principal Investigator: Cheng, Genhong
Sponsor Name: Amgen
Award Title: Mechanisms of Therapeutic Protein Aggregate Induced Immunogenicity: Feasibility Study
Principal Investigator: Cloughesy, Timothy
Sponsor Name: Astrazeneca
Award Title: Open Label, Multi-Center, Iressa Clinical Access Program of Gefitinib 250mg (Iressa) for the Continued Treatment of Patients in the United States
Principal Investigator: de Vos, Sven
Sponsor Name: Pharmacyclics
Award Title: Randomized, Multicenter, Open-Label, Phase 3 Study of the Bruton's Tyrosine Kinase (Btk) Inhibitor Ibrutinib Versus Ofatumumab
Principal Investigator: Dorshkind, Kenneth
Sponsor Name: NIH/Center for Scientific Review
Award Title: Impact of B-Cell Lineage On Progression of B-Acute Lymphoblastic Leukemia
Principal Investigator: Federman, Noah
Sponsor Name: Nanosmart Pharmaceuticala, Inc.
Award Title: Development and Delivery of Nanosmart Immunoliposomes to Bone and Soft Tissue Sarcomas
Principal Investigator: Finn, Richard
Sponsor Name: Novartis Pharmaceuticals (Novartis Ag)
Award Title: In Vivo Evaluation of Pi3k Compounds (Bkm120, Bez235 and Rad001) in EFE184 Endometrial Model (Pi3k, Pten and Kras Wt)
Principal Investigator: Finn, Richard
Sponsor Name: Novartis Pharmaceuticals (Novartis Ag (Incl Pharma,Animal Hl
Award Title: In Vivo Evaluation of Pi3k Compounds (Bkm120; Byl719; Bez235 Rad001) in Combination with Trastuzimab in Acquired Trastuzimab Resistant Model BT-TR
Principal Investigator: Finn, Richard
Sponsor Name: Novartis Pharmaceuticals (Novartis Ag)
Award Title: In Vivo Evaluation of Pi3k Compounds (Bkm120; Byl719; Rad001) in Combination with Fluvestrant in Both the Er+ Models, Kpl-1 and Mcf-7
Principal Investigator: Garraway, Isla
Sponsor Name: Charles R. Drew University of Medicine & Science
Award Title: Ancestral Differences in Prostate Stem/Progenitor Cell Abundance and Activity in Prostate Cancer
Principal Investigator: Glaspy, John
Sponsor Name: Clinical Research Management, Inc
Award Title: Phase II, Randomized, Multi-Centre, Open-Label, Active-Controlled, Dose-Finding Trial of F-627 in Women with Breast Cancer Receiving Myelotoxic Chem
Principal Investigator: Kabbinavar, Fairooz
Sponsor Name: Kite Pharma, Inc.
Award Title: Phase I, Open Label, Dose Escalation and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced
Principal Investigator: Maynard, Heather
Sponsor Name: Phytex LLC
Award Title: Stabilizing Enzymes
Principal Investigator: Nelson, Stanley
Sponsor Name: Stanford University
Award Title: Signaling Pathways in Pathogenesis of Diamond Blackfan Anemia
Principal Investigator: Pietras, Richard
Sponsor Name: Charles R. Drew University of Medicine & Science
Award Title: Biologic Factors in Triple-Negative Breast Cancer Health Disparities
Principal Investigator: Reiter, Robert
Sponsor Name: Prostate Cancer Foundation
Award Title: Preventing Treatment Resistance by Co-Targeting of Androgen Receptor and SRC/MEK1-Dependentt Epithelia to Mesenchymal Transition
Principal Investigator: Ritz, Beate
Sponsor Name: NIH/National Institute of Environmental Health Sciences
Award Title: Air Pollution and Parkinson's in the Danish Pasida Study
Principal Investigator: Torres, Jorge
Sponsor Name: National Science Foundation
Award Title: Dissecting the Mechanisms of Cell Division
Principal Investigator: Waschek, James
Sponsor Name: NIH/National Institute of Mental Health
Award Title: Pacap Signaling in Fear Circuitries Relevant to Post-Trauamatic Stress Disorder
Principal Investigator: Wu, Anna
Sponsor Name: Imaginab, Inc.
Award Title: Novel Small Human Protein Scaffold for In Vivo Molecular Imaging